Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
7
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
7
×
national top stories
new york blog main
new york top stories
pfizer
7
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
7
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
alzheimer's disease
deals
amgen
bristol-myers squibb
cancer
cancer immunotherapy
celgene
clinical trials
eli lilly
medicare
novartis
What
bio
roundup
drug
alzheimer’s
billions
biotech
crispr
days
gene
news
patients
prices
week
acquisitions
aducanumab
albert
alliance
amyloid
angst
annual
assessed
attention
august
bagged
becker
biggest
biogen
biogen’s
bourla
brammer
bristol
busy
buy
calls
ceo
changing
color
communities
companies
company
Language
unset
unknown
Current search:
biogen
×
" seattle top stories "
×
pfizer
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More